Accretion Pharmaceuticals Ltd

NSE: ACCPL · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹185.30
Market cap: ₹206.0 Cr
Revenue (annual): ₹89.63 Cr
Net profit (annual): ₹9.67 Cr
P/E (TTM): 21.3×Sector 47.4×
Promoter holding: 73.52%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Annual General Meeting 3 Financial Results 2 Results Correction 1 Management Change 1 Earnings Call 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 May 2026 17:42 IST NSE

Board Meeting Outcome

Accretion Pharmaceuticals Board Meeting Outcome

Accretion Pharmaceuticals approved the appointment of a new HR Manager and internal/secretarial auditors. These appointments strengthen the company's leadership and regulatory compliance frameworks.

Execution: 12 months

Read the filing ↗